EVKEEZA is an injectable prescription medicine used along with other low-density lipoprotein (LDL) lowering medicines in people 5 years of age and older with a type of high cholesterol …

EVKEEZA is indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 5 years and older, with …

Evinacumab, sold under the brand name Evkeeza, is a monoclonal antibody medication for the treatment of homozygous familial hypercholesterolemia (HoFH). [4] [5] [6] Common side …

2024年2月25日 · Evkeeza (evinacumab) belongs to a class of medications called angiopoietin-like protein 3 (ANGPTL3) inhibitor monoclonal antibodies. Evkeeza injection is used with other …

2021年2月11日 · Evkeeza is the first FDA-approved treatment that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism.

2021年4月23日 · Evkeeza is a medicine used together with low-fat diet and other medicines to reduce levels of cholesterol in the blood. It is used in adults, adolescents and children aged 6 …

EVKEEZA is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated as an adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and …

2025年1月13日 · EVKEEZA is an injectable prescription medicine used along with other low-density lipoprotein (LDL) lowering medicines in people 5 years of age and older with a type of …

2025年3月14日 · When Evkeeza blocks the action of ANGPTL3, "bad" cholesterol (known as LDL cholesterol) can be cleared from the body in patients with Homozygous Familial …

2023年10月2日 · Evkeeza (evinacumab or evinacumab-dgnb) is a monoclonal antibody that treats homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that causes …